Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000902664-25-002786·ENZO BIOCHEM INC
Schedule 13D ownership disclosure
ENZO BIOCHEM INC
Common Stock, par value $0.01 per share · CUSIP: 294100102
Event date: 2025-06-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Harbert Discovery Fund, LPReported CIK 0001626127
Shares: 1,763,493.00 · Class: 3.36%
- Harbert Discovery Fund GP, LLCReported CIK 0001642538
Shares: 1,763,493.00 · Class: 3.36%
- Harbert Discovery Co-Investment Fund I, LPReported CIK 0001771491
Shares: 3,412,420.00 · Class: 6.51%
- Harbert Discovery Co-Investment Fund I GP, LLCReported CIK 0001771499
Shares: 3,412,420.00 · Class: 6.51%
- Harbert Fund Advisors, Inc.Reported CIK 0001616659
Shares: 5,175,913.00 · Class: 9.87%
- Harbert Management CorporationReported CIK 0001259933
Shares: 5,175,913.00 · Class: 9.87%
- Jack Bryant
Shares: 5,175,913.00 · Class: 9.87%
- Kenan Lucas
Shares: 5,175,913.00 · Class: 9.87%
- Raymond Harbert
Shares: 5,175,913.00 · Class: 9.87%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-002786
- Form type
- SCHEDULE 13D/A
- Filer
- ENZO BIOCHEM INC
- CIK
- CIK 316253
- Filed
- Jun 25, 2025
- Reporting period
- Jun 23, 2025
- Description
- Schedule 13D beneficial ownership